<unk>  (or SpikoGen) is the result of a collaboration between Vaxine and CinnaGen, a private company with operations in the Middle East.<unk>  is a recombinant protein-based COVID-19 vaccine developed by South Australian-based biotech company Vaxine. It is under clinical trial in collaboration with the Iranian company CinnaGen.
COVAX-19
BGR-34
Rc-o319
CURB-65
QS-21
CARB-X
C-KAD
AP-7 